A jury has presented $8.2 million to a 60-year-old Texas man fighting MDS/AML. It’s a type of leukemia triggered by his exposure to benzene, contained in paint and thinners mass-produced by E.I. Du Pont De Nemours. Virgil Hood touched DuPont’s toxic merchandises on the job every day in Colorado between 1973 and 1996. He operated as a painter for Timpte Trailers, an establishment that makes semi-trailers, and Continental Airlines.
“As soon as DuPont figured that the government was in view of a safety standard, it believed only of expenses to its business,” held Suzi Chester, Waters Kraus & Paul lawyer and co-counsel at trial. “Reasonably than simply put a cancer cautionary on its paints, DuPont’s expert presented careless test results to OSHA that were not anywhere near real-world circumstances. DuPont’s overcome testing was planned to create the lie that workers exposed to benzene levels 5 to 10 times over the proposed standard would still be harmless,” Kraus added.
Hood was identified with MDS/AML in 2012 afterwards a routine physical checkup. “Ever since then, Mr. Hood has been struggling with the illness every day,” alleged Chester. Hood received exhausting chemotherapy cures and after being positioned on a waitlist at MD Anderson Cancer Center in Houston. He experienced a bone marrow transplant that caused in terrible complications, as well as three bouts of pneumonia and brief blindness. “At one stage, his weight fell to 110 pounds but Virgil kept back fighting,” Chester sustained.
On October 20, after a two-week trial, the jury gave Virgil Hood $8,243,234, as well as $6,743,234 in compensatory costs and $1.5 million in punitive compensations against DuPont. DuPont is accountable for 80% of the compensatory outcome. And Mr. Hood’s ex- employer, Timpte, is liable for the outstanding 20%. Kraus and Chester were supported at trial by Jonathan George.
Throughout trial, Mr. Hood was fighting graft-versus-host illness, in which his body and the new bone marrow are factually attacking one another. The drugs that stop his body from refusing the new bone marrow results side effects that Mr. Hood survives with day by day. After working over his chemotherapy cures, Mr. Hood was forced to stop working after the operation. “He merely could not go on,” Chester described. “Virgil gets it one day at a time now. But he & Lorrie have hope – that certainly is unbelievable given what they’ve underwent” enhances Chester.
We wish Mr. Hood all the best for his glowing future.
By: Hanson Smith, Structured Settlement Expert